Clinical Trial Update: "Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Red Morphine Drops for dyspnea in lung cancer has completed. Sponsor: Sankt Lukas Hospice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Red Morphine Drops (Morphine)

Snippet

Sponsor: Sankt Lukas Hospice | Conditions: Dyspnea, Lung Neoplasms | Phase 4 | Status: COMPLETED